Recently, biomarkers that reflect the effects of various ICIs, such as tumor cell PD-L1 expression, tumor mutational burden, neoantigen burden, polybromo-1 gene mutation, immune cell infiltration, and intestinal microbiota, have been investigated [9]. Here, CD274 is linked to neoplasm.